ESR1 and breast carcinoma: As CBFB is included on all major cancer gene panels, this biomarker requires no additional testing infrastructure for clinical implementation.<h4>Cbfb translational relevance</h4>Endocrine therapy is the standard of care for estrogen receptor (ER)-positive breast cancer.